ID: ALA2398562

Max Phase: Preclinical

Molecular Formula: C12H11N3

Molecular Weight: 197.24

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CN1c2ccccc2N=Cc2cccn21

Standard InChI:  InChI=1S/C12H11N3/c1-14-12-7-3-2-6-11(12)13-9-10-5-4-8-15(10)14/h2-9H,1H3

Standard InChI Key:  ZIWGZWWTTHKXKH-UHFFFAOYSA-N

Associated Targets(non-human)

Schistosoma japonicum 780 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 197.24Molecular Weight (Monoisotopic): 197.0953AlogP: 2.45#Rotatable Bonds: 0
Polar Surface Area: 20.53Molecular Species: NEUTRALHBA: 3HBD: 0
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 6.70CX LogP: 2.35CX LogD: 2.28
Aromatic Rings: 2Heavy Atoms: 15QED Weighted: 0.63Np Likeness Score: -0.38

References

1. Chen J, Sun W, Yang J, Sun H, Wang Z, Dong L, Qiao C, Xia CM..  (2013)  Development of a novel class of pyrrolo-[1,2,5]benzothiadiazepine derivatives as potential anti-schistosomal agents.,  23  (13): [PMID:23707253] [10.1016/j.bmcl.2013.04.085]

Source